Zinaida Tigay

Eng koʻp iqtibos qilingan asarlar

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis20228 iqtibos
2. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20164 iqtibos
3. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan20203 iqtibos
4. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study20141 iqtibos
5. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan20181 iqtibos
6. Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan20241 iqtibos
7. The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan20251 iqtibos
8. Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan20201 iqtibos
9. Patient and health-care worker perspectives on the short-course regimen for treatment of drug-resistant tuberculosis in Karakalpakstan, Uzbekistan20201 iqtibos
10. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen20150 iqtibos

Hammualliflar

1. Nargiza Parpieva9 ta umumiy asar2015–2025
2. Philipp du Cros6 ta umumiy asar2015–2022
3. Jay Achar5 ta umumiy asar2015–2020
4. Khasan Safaev4 ta umumiy asar2020–2025
5. Catherine Berry4 ta umumiy asar2015–2022
6. Bern-Thomas Nyang’wa3 ta umumiy asar2016–2022
7. Atadjan Khamraev3 ta umumiy asar2015–2020
8. Shona Horter3 ta umumiy asar2016–2020
9. Beverley Stringer3 ta umumiy asar2016–2020
10. Jane Greig3 ta umumiy asar2016–2020

Barcha hammualliflar →